Cipla Europe

Antwerpen ·KBO/BCE: BE 0539.790.548

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	8.6%	42.0%	better than 13% of 184 sector peers
Net result	€-1.32M	€164k	better than 5% of 184 sector peers
Equity	€3.50M	€1.23M	better than 70% of 184 sector peers
Staff costs	€2.78M	€777k	higher than 71% of 140 sector peers
Total assets	€40.76M	€3.31M	better than 86% of 184 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€40.76M
Fixed assets	21/28	€1.36M
Intangible fixed assets	21	€1.24M
Tangible fixed assets	22/27	€28k
Financial fixed assets	28	€92k
Current assets	29/58	€39.40M
Stocks & contracts in progress	3	€5.94M
Amounts receivable within one year	40/41	€32.38M
Cash & bank	54/58	€929k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€40.76M
Equity	10/15	€3.50M
Contributions / capital	10/11	€7.10M
Reserves	13	€110k
Accumulated profits (losses)	14	€-3.71M
Provisions & deferred taxes	16	€378k
Amounts payable	17/49	€36.89M
Amounts payable within one year	42/48	€36.30M
Trade debts payable within one year	44	€34.78M
Income statement
Turnover	70	€24.78M
Operating result	9901	€-219k
Financial income	75	€211k
Financial charges	65	€1.25M
Result before taxes	9903	€-1.26M
Income taxes	67/77	€59k
Net result for the period	9904	€-1.32M
Result to be appropriated	9905	€-1.32M

NACE primary	Groothandel in farmaceutische en medische artikelen(46460)
Legal form	Public limited company(014)
Incorporation	30-09-2013
Status	Active
Postal code	2018
First BS signal	10-10-2018
Latest BS signal	17-10-2018

Summary